| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $76.3M | +0.4% |
| R&D Expense | $134.6M | -6.3% |
| SG&A Expense | $61.5M | -12.7% |
| Operating Income | -$137.1M | +0.7% |
| Pre-tax Income | -$116.6M | +2.2% |
| Income Tax | $6.1M | +1171.1% |
| Net Income | -$122.7M | -3.4% |
| EPS (Basic) | -$1.62 | +5.8% |
| EPS (Diluted) | -$1.62 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $66.1M | -58.0% |
| Accounts Receivable | $55.8M | +186.6% |
| Current Assets | $300.5M | -27.2% |
| Total Assets | $463.1M | -20.3% |
| Current Liabilities | $88.3M | +58.3% |
| Total Liabilities | $124.3M | +7.1% |
| Stockholders' Equity | $338.8M | -27.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$110.0M | +7.0% |
| Capital Expenditures | $2.0M | -19.5% |
| Investing Cash Flow | $38.8M | +118.7% |
| Financing Cash Flow | -$20.5M | -125.0% |
| Free Cash Flow | -$112.0M | +7.2% |
| +5.8% |